These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. A promoter region of the midkine gene that is frequently expressed in human hepatocellular carcinoma can activate a suicide gene as effectively as the alpha-fetoprotein promoter. Tomizawa M; Yu L; Wada A; Tamaoki T; Kadomatsu K; Muramatsu T; Matsubara S; Watanabe K; Ebara M; Saisho H; Sakiyama S; Tagawa M Br J Cancer; 2003 Sep; 89(6):1086-90. PubMed ID: 12966430 [TBL] [Abstract][Full Text] [Related]
3. Expression of β-catenin protein in hepatocellular carcinoma and its relationship with alpha-fetoprotein. Ren YJ; Huang T; Yu HL; Zhang L; He QJ; Xiong ZF; Peng H J Huazhong Univ Sci Technolog Med Sci; 2016 Dec; 36(6):846-851. PubMed ID: 27924522 [TBL] [Abstract][Full Text] [Related]
4. TCP10L acts as a tumor suppressor by inhibiting cell proliferation in hepatocellular carcinoma. Zuo J; Cai H; Wu Y; Ma H; Jiang W; Liu C; Han D; Ji G; Yu L Biochem Biophys Res Commun; 2014 Mar; 446(1):61-7. PubMed ID: 24565846 [TBL] [Abstract][Full Text] [Related]
5. Effects of alpha-fetoprotein on the occurrence and progression of hepatocellular carcinoma. Zheng Y; Zhu M; Li M J Cancer Res Clin Oncol; 2020 Oct; 146(10):2439-2446. PubMed ID: 32725355 [TBL] [Abstract][Full Text] [Related]
6. p55PIK regulates alpha-fetoprotein expression through the NF-κB signaling pathway. Ye G; Sun G; Cheng Z; Zhang L; Hu K; Xia X; Zhou Y Life Sci; 2017 Dec; 191():104-110. PubMed ID: 28970114 [TBL] [Abstract][Full Text] [Related]
7. Expression of alpha-fetoprotein and albumin genes in human hepatocellular carcinomas: limitations in the application of the genes for targeting human hepatocellular carcinoma in gene therapy. Ohguchi S; Nakatsukasa H; Higashi T; Ashida K; Nouso K; Ishizaki M; Hino N; Kobayashi Y; Uematsu S; Tsuji T Hepatology; 1998 Feb; 27(2):599-607. PubMed ID: 9462663 [TBL] [Abstract][Full Text] [Related]
8. Up-regulated aldo-keto reductase family 1 member B10 in chronic hepatitis C: association with serum alpha-fetoprotein and hepatocellular carcinoma. Sato S; Genda T; Hirano K; Tsuzura H; Narita Y; Kanemitsu Y; Kikuchi T; Iijima K; Wada R; Ichida T Liver Int; 2012 Oct; 32(9):1382-90. PubMed ID: 22681639 [TBL] [Abstract][Full Text] [Related]
9. Downregulation of LHPP Expression Associated with AFP Acts as a Good Prognostic Factor in Human Hepatocellular Carcinoma. Chao X; Zhang W; Wu J; Feng X; Shi H; Zhao L; Shen H; Jiang C Biomed Res Int; 2021; 2021():1971048. PubMed ID: 34485511 [TBL] [Abstract][Full Text] [Related]
10. TUG1 Is a Regulator of AFP and Serves as Prognostic Marker in Non-Hepatitis B Non-Hepatitis C Hepatocellular Carcinoma. Lin YH; Wu MH; Huang YH; Yeh CT; Lin KH Cells; 2020 Jan; 9(2):. PubMed ID: 31973032 [TBL] [Abstract][Full Text] [Related]
11. Icaritin promotes apoptosis and inhibits proliferation by down-regulating AFP gene expression in hepatocellular carcinoma. Li H; Liu Y; Jiang W; Xue J; Cheng Y; Wang J; Yang R; Zhang X BMC Cancer; 2021 Mar; 21(1):318. PubMed ID: 33765973 [TBL] [Abstract][Full Text] [Related]
12. ZHX2 is a repressor of alpha-fetoprotein expression in human hepatoma cell lines. Shen H; Luan F; Liu H; Gao L; Liang X; Zhang L; Sun W; Ma C J Cell Mol Med; 2008 Dec; 12(6B):2772-80. PubMed ID: 18194454 [TBL] [Abstract][Full Text] [Related]
13. An Insight Into the Role of Alpha-Fetoprotein (AFP) in the Development and Progression of Hepatocellular Carcinoma. Samban SS; Hari A; Nair B; Kumar AR; Meyer BS; Valsan A; Vijayakurup V; Nath LR Mol Biotechnol; 2024 Oct; 66(10):2697-2709. PubMed ID: 37782430 [TBL] [Abstract][Full Text] [Related]
14. α-Fetoprotein promoter-driven Cre/LoxP-switched RNA interference for hepatocellular carcinoma tissue-specific target therapy. Peng YF; Shi YH; Ding ZB; Zhou J; Qiu SJ; Hui B; Gu CY; Yang H; Liu WR; Fan J PLoS One; 2013; 8(2):e53072. PubMed ID: 23468839 [TBL] [Abstract][Full Text] [Related]
15. The targeted expression of the human interleukin-2/interferon alpha2b fused gene in alpha-fetoprotein-expressing hepatocellular carcinoma cells. He P; Tang ZY; Liu BB; Ye SL; Liu YK J Cancer Res Clin Oncol; 1999; 125(2):77-82. PubMed ID: 10190313 [TBL] [Abstract][Full Text] [Related]
16. [Differential analysis of gene expression profiles in hepatocellular carcinoma patients with high and low levels of alpha-fetoprotein]. Wang XJ; Shen RF; Wang X; Wang YR; Xiao T Zhonghua Zhong Liu Za Zhi; 2020 May; 42(5):396-402. PubMed ID: 32482029 [No Abstract] [Full Text] [Related]
17. [The methylation of ZHX2 gene promoter enhances AFP gene expression in hepatocellular carcinoma]. Lv Z; DU Y; Wen J Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2013 Jul; 29(7):706-9. PubMed ID: 23837980 [TBL] [Abstract][Full Text] [Related]
18. Modulation of miR-29 expression by α-fetoprotein is linked to the hepatocellular carcinoma epigenome. Parpart S; Roessler S; Dong F; Rao V; Takai A; Ji J; Qin LX; Ye QH; Jia HL; Tang ZY; Wang XW Hepatology; 2014 Sep; 60(3):872-83. PubMed ID: 24798303 [TBL] [Abstract][Full Text] [Related]
19. AFP promotes HCC progression by suppressing the HuR-mediated Fas/FADD apoptotic pathway. Chen T; Dai X; Dai J; Ding C; Zhang Z; Lin Z; Hu J; Lu M; Wang Z; Qi Y; Zhang L; Pan R; Zhao Z; Lu L; Liao W; Lu X Cell Death Dis; 2020 Oct; 11(10):822. PubMed ID: 33009373 [TBL] [Abstract][Full Text] [Related]
20. Combined serum hepatoma-specific alpha-fetoprotein and circulating alpha-fetoprotein-mRNA in diagnosis of hepatocellular carcinoma. Wu W; Yao DF; Yuan YM; Fan JW; Lu XF; Li XH; Qiu LW; Zong L; Wu XH Hepatobiliary Pancreat Dis Int; 2006 Nov; 5(4):538-44. PubMed ID: 17085339 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]